JTT-252

JTT-252 · Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JTT-252, covering 2015-05-01 to 2015-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252 [Phase 1]